• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心房颤动患者抗栓治疗的临床指南可通过数据采集在全科医疗中实施]

[Clinical guidelines for antithrombotic therapy of patients with atrial fibrillation can be implemented in general practice by means of data capture].

作者信息

Larsen Susanne Lis, Sønderstrup Dines, Sønderstrup Jakob, Toft Jens Christian

机构信息

Lægehuset i Borup, Hovedgaden 16, 4140 Borup, Denmark.

出版信息

Ugeskr Laeger. 2012 Sep 17;174(38):2227-9.

PMID:22992480
Abstract

Suboptimal treatment with oral anticoagulation therapy of atrial fibrillation is well-documented. The use of clinical guidelines and databases in general practice can improve adherence to the guidelines stipulated by the Danish Society of Cardiology. However, guidelines should be updated continuously, and in approximately 20% of our patients the application of oral anticoagulation therapy turned out to be problematic, even though they had a high thromboembolic risk score.

摘要

房颤口服抗凝治疗的不充分情况有充分记录。在全科医疗中使用临床指南和数据库可提高对丹麦心脏病学会规定指南的依从性。然而,指南应持续更新,并且在我们约20%的患者中,尽管他们有高血栓栓塞风险评分,但口服抗凝治疗的应用仍存在问题。

相似文献

1
[Clinical guidelines for antithrombotic therapy of patients with atrial fibrillation can be implemented in general practice by means of data capture].[心房颤动患者抗栓治疗的临床指南可通过数据采集在全科医疗中实施]
Ugeskr Laeger. 2012 Sep 17;174(38):2227-9.
2
[Antithrombotic therapy in patients with atrial fibrillation: a comment on the European guidelines].[心房颤动患者的抗栓治疗:对欧洲指南的评论]
Dtsch Med Wochenschr. 2011 Jun;136(25-26):1384-5. doi: 10.1055/s-0031-1280560. Epub 2011 Jun 14.
3
Recent advances in oral anticoagulation for atrial fibrillation.心房颤动口服抗凝治疗的最新进展
Ther Adv Cardiovasc Dis. 2010 Dec;4(6):395-407. doi: 10.1177/1753944710386844. Epub 2010 Oct 21.
4
Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.基于人群的心房颤动抗栓治疗管理评估
Can J Cardiol. 2005 Mar;21(3):257-66.
5
[Nonvalvular atrial fibrillation: thromboembolic risk assessment and therapy in a general practice population].[非瓣膜性心房颤动:全科医疗人群中的血栓栓塞风险评估与治疗]
G Ital Cardiol (Rome). 2010 Apr;11(4):313-7.
6
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.加拿大心血管学会 2010 年心房颤动指南:预防心房颤动和心房扑动中的脑卒中及全身性血栓栓塞
Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.
7
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.
8
[Risk stratification for thromboembolism and antithrombotic prophylaxis in atrial fibrillation].[心房颤动血栓栓塞的风险分层与抗栓预防]
G Ital Cardiol (Rome). 2012 Nov;13(11 Suppl 1):11S-18S. doi: 10.1714/1179.13062.
9
Atrial fibrillation and thromboembolic risk: what is the extent of adherence to guidelines in clinical practice?
Rev Port Cardiol. 2011 Feb;30(2):171-80.
10
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.基于社区队列研究的 CHA2DS2-VASc 评分为 0 的心房颤动患者的预后。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.